Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including medication adherence, communications solutions, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc. has a strategic agreement with Daiichi Sankyo, Inc. for the development of Daiichi Sankyo'S Adc oncology pipeline; and a partnership with VBI Vaccines Inc. for the commercialization of VBI's 3-antigen prophylactic hepatitis B vaccine in the United States, Europe, and Canada, which is in pending regulatory approvals. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Meggs Jason M. | Chief Financial Officer | Jan 06 | Sale | 72.00 | 5,552 | 399,744 | 58,951 | Jan 07 05:03 PM | Macdonald Alistair | Chief Executive Officer | Dec 23 | Sale | 70.52 | 300 | 21,155 | 245,187 | Dec 28 05:07 PM | Macdonald Alistair | Chief Executive Officer | Dec 22 | Sale | 70.02 | 1,200 | 84,020 | 245,487 | Dec 28 05:07 PM | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Dec 03 | Sale | 61.28 | 3,228,241 | 197,826,608 | 15,418,795 | Dec 07 05:27 PM | Allen Tom | Director | Dec 03 | Sale | 61.28 | 3,228,241 | 197,826,608 | 15,418,795 | Dec 07 05:26 PM | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Dec 03 | Sale | 61.28 | 3,228,241 | 197,826,608 | 15,418,795 | Dec 07 05:25 PM | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Dec 03 | Sale | 61.28 | 3,228,241 | 197,826,608 | 15,418,795 | Dec 07 05:22 PM | Maldonado John L. | Director | Dec 03 | Sale | 61.28 | 3,228,241 | 197,826,608 | 15,418,795 | Dec 07 05:18 PM | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Dec 03 | Sale | 61.28 | 3,228,241 | 197,826,608 | 15,418,795 | Dec 07 05:13 PM | THOMAS H. LEE ADVISORS, LLC | Director | Dec 03 | Sale | 61.28 | 2,771,132 | 169,814,969 | 13,235,545 | Dec 07 05:09 PM | THOMAS H. LEE ADVISORS, LLC | Director | Dec 03 | Sale | 61.28 | 627 | 38,423 | 831 | Dec 07 05:09 PM | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Dec 03 | Sale | 61.28 | 3,228,241 | 197,826,608 | 15,418,795 | Dec 07 05:07 PM | THOMAS H. LEE ADVISORS, LLC | Director | Dec 03 | Sale | 61.28 | 2,771,132 | 169,814,969 | 13,235,545 | Dec 07 05:05 PM | THOMAS H. LEE ADVISORS, LLC | Director | Dec 03 | Sale | 61.28 | 627 | 38,423 | 831 | Dec 07 05:05 PM | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Dec 03 | Sale | 61.28 | 3,228,241 | 197,826,608 | 15,418,795 | Dec 07 04:53 PM | Meggs Jason M. | Chief Financial Officer | Nov 27 | Sale | 67.00 | 4,062 | 272,154 | 66,003 | Nov 30 05:12 PM | Meggs Jason M. | Chief Financial Officer | Nov 24 | Sale | 67.00 | 1,938 | 129,846 | 70,065 | Nov 25 05:01 PM | KEEFE MICHELLE | Pres., Commercial Solutions | Nov 18 | Sale | 65.00 | 856 | 55,640 | 48,881 | Nov 19 05:00 PM | KEEFE MICHELLE | Pres., Commercial Solutions | Nov 17 | Sale | 62.65 | 800 | 50,120 | 49,643 | Nov 19 05:00 PM | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Sep 17 | Sale | 59.26 | 3,766,281 | 223,189,812 | 18,647,036 | Sep 21 09:56 PM | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Sep 17 | Sale | 59.26 | 3,766,281 | 223,189,812 | 18,647,036 | Sep 21 09:56 PM | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Sep 17 | Sale | 59.26 | 3,766,281 | 223,189,812 | 18,647,036 | Sep 21 09:55 PM | Allen Tom | Director | Sep 17 | Sale | 59.26 | 3,766,281 | 223,189,812 | 18,647,036 | Sep 21 09:55 PM | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Sep 17 | Sale | 59.26 | 3,766,281 | 223,189,812 | 18,647,036 | Sep 21 09:55 PM | Maldonado John L. | Director | Sep 17 | Sale | 59.26 | 3,766,281 | 223,189,812 | 18,647,036 | Sep 21 09:54 PM | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Sep 17 | Sale | 59.26 | 3,766,281 | 223,189,812 | 18,647,036 | Sep 21 09:54 PM | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Sep 17 | Sale | 59.26 | 3,766,281 | 223,189,812 | 18,647,036 | Sep 21 09:53 PM | THOMAS H. LEE ADVISORS, LLC | Director | Sep 17 | Sale | 59.26 | 3,232,987 | 191,586,810 | 16,006,677 | Sep 21 05:39 PM | THOMAS H. LEE ADVISORS, LLC | Director | Sep 17 | Sale | 59.26 | 732 | 43,378 | 1,005 | Sep 21 05:39 PM | THOMAS H. LEE ADVISORS, LLC | Director | Sep 17 | Sale | 59.26 | 3,232,987 | 191,586,810 | 16,006,677 | Sep 21 05:30 PM | THOMAS H. LEE ADVISORS, LLC | Director | Sep 17 | Sale | 59.26 | 732 | 43,378 | 1,005 | Sep 21 05:30 PM | Macdonald Alistair | Chief Executive Officer | Aug 03 | Sale | 65.07 | 10,289 | 669,464 | 246,687 | Aug 04 05:06 PM | Macdonald Alistair | Chief Executive Officer | Jul 15 | Option Exercise | 16.06 | 37,868 | 608,160 | 280,088 | Jul 17 05:03 PM | Macdonald Alistair | Chief Executive Officer | Jul 15 | Sale | 60.14 | 37,868 | 2,277,495 | 261,154 | Jul 17 05:03 PM | Macdonald Alistair | Chief Executive Officer | Jul 14 | Option Exercise | 10.57 | 5,173 | 54,679 | 266,327 | Jul 15 05:03 PM | Macdonald Alistair | Chief Executive Officer | Jul 14 | Sale | 58.68 | 5,173 | 303,553 | 261,154 | Jul 15 05:03 PM | Macdonald Alistair | Chief Executive Officer | Jul 13 | Option Exercise | 10.57 | 3,655 | 38,633 | 264,809 | Jul 15 05:03 PM | Macdonald Alistair | Chief Executive Officer | Jul 13 | Sale | 58.21 | 3,655 | 212,747 | 261,154 | Jul 15 05:03 PM | Dineen John M. | Director | Jul 06 | Buy | 59.11 | 8,691 | 513,725 | 17,426 | Jul 08 05:04 PM | KEEFE MICHELLE | Pres., Commercial Solutions | Jul 06 | Sale | 59.11 | 1,500 | 88,665 | 50,443 | Jul 08 05:06 PM | KEEFE MICHELLE | Pres., Commercial Solutions | May 20 | Sale | 60.00 | 2,500 | 150,000 | 51,943 | May 21 05:01 PM | Parks Robert | EVP, Chief Accounting Officer | Apr 20 | Sale | 49.65 | 3,588 | 178,144 | 12,450 | Apr 21 07:04 PM | Meggs Jason M. | Chief Financial Officer | Mar 20 | Buy | 36.74 | 3,555 | 130,613 | 63,829 | Mar 23 05:04 PM | COLVIN PAUL | Pres., Clinical Solutions | Mar 19 | Buy | 36.65 | 1,300 | 47,645 | 26,855 | Mar 23 05:06 PM | Meggs Jason M. | Chief Financial Officer | Mar 05 | Option Exercise | 0.00 | 5,094 | 0 | 68,923 | Apr 15 06:39 PM | Macdonald Alistair | Chief Executive Officer | Mar 05 | Option Exercise | 0.00 | 31,258 | 0 | 248,937 | Apr 15 06:55 PM |
|